CME CME Group

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Global derivatives exchange operator: trading, clearing, and data services across interest rates, equities, FX, commodities, and crypto
• • Two new 2025 platform launches: BrokerTec Chicago (second CLOB for cash U.S. Treasuries co-located with futures) and FX Spot+ (connects OTC spot FX with futures liquidity)
• • CMESC received SEC approval in December 2025 to become a securities clearing agency, targeting U.S. Treasury (Dec 2026) and repo (June 2027) clearing mandates
• • Record ADV of 28.1 million contracts in 2025; micro products +32% YoY, Asia Pacific trading hours volume +13% YoY
• • Joint venture with FanDuel (Flutter Entertainment) launched December 2025 — retail prediction markets app covering financial, economic, and sporting event contracts

Risk Factors

• • FMX Futures Exchange and prediction market platforms (via FanDuel JV) directly targeting CME's derivatives and event-contract segments; litigation ongoing across multiple jurisdictions
• • Basel III Endgame and potential GSIB capital surcharge changes could raise bank clearing firm capital requirements, reducing their trading activity in CME markets
• • CyrusOne data center cooling failure (November 27, 2025) forced temporary market halt; single largest data center represents unhedged operational concentration
• • $3.4B total debt outstanding as of December 31, 2025, with $2.3B additional borrowing capacity; fixed-cost structure amplifies earnings risk in low-volume environments
• • 85% of 2025 derivatives contract volume from members holding board seats and conflicting economic interests vs. Class A shareholders

Management Discussion & Analysis

• • Revenue $6,520.6M in 2025, up ~6.4% YoY from $6,130.1M; clearing & transaction fees $5,281.1M (+5.9%), market data $803.1M (+13.1%)
• • Operating margin 64.9% vs 64.1% in 2024; net income $4,072.2M vs $3,525.8M; diluted EPS $11.16 vs $9.67
• • Best segment: market data +$92.9M YoY; contract volume up 5.6% to 7,060.4M driven by interest rates (+3.6%) and equity indexes (+8.2%); FX weakest, volume down ~5%
• • Operating cash flow $4,277.1M vs $3,690.5M; capex guided ~$85M for 2026; $2.7B remaining under $3.0B buyback authorization; variable dividend $6.15/share plus quarterly $1.30/share declared Feb 2026
• • Key risks: tariff uncertainty, Fed rate policy, competitive intensity; OSTTRA JV sold in Q4 2025 generating $306.1M gain; Google Cloud transformation ongoing with shifting cost profile

What are the latest CME SEC filings in 2026?

CME Group (CME) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on April 24, 2026, an 8-K current report on July 22, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did CME file its most recent 10-K annual report?

CME Group (CME) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view CME 10-Q quarterly reports?

CME Group (CME)'s most recent 10-Q quarterly report was filed on April 24, 2026. SignalX displays every CME 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has CME filed recently?

CME Group (CME)'s most recent 8-K was filed on July 22, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find CME insider trading activity (Form 4)?

SignalX aggregates every CME Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does CME file with the SEC?

CME Group (CME) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CME filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for CME Group (CME).

What is CME's SEC CIK number?

CME Group (CME)'s SEC CIK (Central Index Key) number is 1156375. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1156375 to look up all CME filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find CME return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from CME Group (CME) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.